Kingswood Wealth Advisors LLC reduced its stake in BlackRock Health Sciences Term Trust (NYSE:BMEZ – Free Report) by 4.4% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 24,293 shares of the company’s stock after selling 1,127 shares during the quarter. Kingswood Wealth Advisors LLC’s holdings in BlackRock Health Sciences Term Trust were worth $346,000 as of its most recent SEC filing.
Several other institutional investors have also added to or reduced their stakes in BMEZ. Royal Bank of Canada lifted its position in BlackRock Health Sciences Term Trust by 326.9% in the 1st quarter. Royal Bank of Canada now owns 1,594,157 shares of the company’s stock valued at $23,753,000 after acquiring an additional 1,220,764 shares in the last quarter. Absolute Investment Advisers LLC lifted its position in BlackRock Health Sciences Term Trust by 112.7% in the 1st quarter. Absolute Investment Advisers LLC now owns 582,256 shares of the company’s stock valued at $8,676,000 after acquiring an additional 308,562 shares in the last quarter. Tabor Asset Management LP bought a new stake in BlackRock Health Sciences Term Trust during the 1st quarter worth about $3,268,000. Quarry LP lifted its position in BlackRock Health Sciences Term Trust by 102.6% during the 1st quarter. Quarry LP now owns 222,175 shares of the company’s stock worth $3,310,000 after buying an additional 112,514 shares in the last quarter. Finally, Penserra Capital Management LLC lifted its position in BlackRock Health Sciences Term Trust by 7.8% during the 1st quarter. Penserra Capital Management LLC now owns 1,122,813 shares of the company’s stock worth $16,729,000 after buying an additional 81,010 shares in the last quarter.
BlackRock Health Sciences Term Trust Price Performance
Shares of NYSE:BMEZ opened at $14.76 on Friday. The company’s 50-day moving average price is $14.31 and its two-hundred day moving average price is $14.29. BlackRock Health Sciences Term Trust has a one year low of $12.58 and a one year high of $16.75.
BlackRock Health Sciences Term Trust Announces Dividend
About BlackRock Health Sciences Term Trust
BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.
See Also
- Five stocks we like better than BlackRock Health Sciences Term Trust
- When to Sell a Stock for Profit or Loss
- 3 Heavily Shorted Stocks That Could Pop on Rate Cuts
- Insider Trades May Not Tell You What You Think
- Broadcom Gets Second $420 Target as CPO Win Boosts Outlook
- Most Volatile Stocks, What Investors Need to Know
- PepsiCo’s Deep Discount Will Soon Evaporate: Buy It While You Can
Want to see what other hedge funds are holding BMEZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Health Sciences Term Trust (NYSE:BMEZ – Free Report).
Receive News & Ratings for BlackRock Health Sciences Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.